Photolithographic synthesis of peptoids.

Photolithographic synthesis of peptoids. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Photolithographic synthesis of peptoids. Abstract Text:

Shuwei Li,Dawn Bowerman,Nishanth Marthandan,Stanley Klyza,Kevin J Luebke,Harold R Garner,Thomas Kodadek,

We describe a novel photolithographic approach to the synthesis of peptoids (oligo-N-substituted glycines). This strategy enables the construction of a spatially addressable peptoid microarray, thus providing a potentially powerful tool for the discovery of protein ligands.

Photolithographic synthesis of peptoids. Publishing Authors By Initials

S Li,D Bowerman,N Marthandan,S Klyza,KJ Luebke,HR Garner,T Kodadek,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Photolithographic synthesis of peptoids. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Journal of the American Chemical Society

VOLUME: 126

Page Numbers: 4088-9

Journal Abbreviation: J. Am. Chem. Soc.

ISSN: 0002-7863

DAY: 7

MONTH: Apr

YEAR: 2004

Photolithographic synthesis of peptoids. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7503056

Photolithographic synthesis of peptoids. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Photolithographic synthesis of peptoids. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Photolithographic synthesis of peptoids.

AFFILIATION: Center for Biomedical Inventions and the Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Am Chem Soc

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Photolithographic synthesis of peptoids Related Publications

• A cell-permeable synthetic transcription factor mimic.
• A convenient, high-throughput assay for measuring the relative cell permeability of synthetic compounds.
• A general system for evaluating the efficiency of chromophore-assisted light inactivation (CALI) of proteins reveals Ru(ii) tris-bipyridyl as an unusually efficient "warhead".
• A peptoid "antibody surrogate" that antagonizes VEGF receptor 2 activity.
• A peptoid antagonist of VEGF receptor 2 recognizes a 'hotspot' in the extracellular domain distinct from the hormone-binding site.
• A potent transactivation domain mimic with activity in living cells.
• Activation Domain-dependent Monoubiquitylation of Gal4 Protein Is Essential for Promoter Binding in Vivo.
• Biochemistry: Molecular cloaking devices.
• Chemistry of periodate-mediated cross-linking of 3,4-dihydroxylphenylalanine-containing molecules to proteins.
• Design and synthesis of a cell-permeable synthetic transcription factor mimic.
• Dynamics of the Hypoxia-inducible Factor-1-Vascular Endothelial Growth Factor Promoter Complex.
• High-throughput evaluation of relative cell permeability between peptoids and peptides.
• Identification of a peptoid inhibitor of the proteasome 19S regulatory particle.
• Label transfer chemistry for the characterization of protein-protein interactions.
• Mixed-element capture agents: a simple strategy for the construction of synthetic, high-affinity protein capture ligands.
• Periodate-triggered cross-linking of DOPA-containing peptide-protein complexes.
• Periodate-triggered cross-linking reveals Sug2/Rpt4 as the molecular target of a peptoid inhibitor of the 19S proteasome regulatory particle.
• Photolithographic synthesis of peptoids.
• Physical and functional interactions of monoubiquitylated transactivators with the proteasome.
• Proteomes take the electrophilic bait.
• Quantitative comparison of the relative cell permeability of cyclic and linear peptides.
• Quantitative evaluation of the relative cell permeability of peptoids and peptides.
• Rapid identification of the pharmacophore in a peptoid inhibitor of the proteasome regulatory particle.
• Selection and application of peptide-binding peptides.
• The neurohormone orexin stimulates hypoxia-inducible factor-1 activity.